What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.69%Above 5Y avg (2.38%)
Annual Rate
KRW 200.00Paid annual
Payout Ratio
45.4%Sustainable
Payback Period
34.0 yr
Last Ex-Dividend
Mar 31, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.59TKRW
1.13B · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
28.91x
vs Conglomerates peers
Updated Aug 19, 2026
Revenue (TTM)
6.85TKRW
4.85B · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
1.41%
vs Conglomerates peers
Updated Aug 19, 2026
Beta
1.24x
vs all stocks
Updated Aug 19, 2026
52-Week Change
64.02%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
1.59TKRW
1.13B · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
2.46TKRW
1.74B · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
28.91x
vs Conglomerates peers
Updated Aug 19, 2026
Forward P/E
20.49x
vs Conglomerates peers
Updated Aug 19, 2026
PEG Ratio
-0.0312x
vs Conglomerates peers
Updated Aug 19, 2026
Price to Sales (TTM)
0.2378x
vs Conglomerates peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.23×.Updated Aug 19, 2026
Price to Book (MRQ)
0.6740x
vs Conglomerates peers
Updated Aug 19, 2026
Enterprise to Revenue
0.3590x
vs Conglomerates peers
Updated Aug 19, 2026
Enterprise to EBITDA
9.43x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 8.64×.Updated Aug 19, 2026
Gross Margin
13.67%
vs Conglomerates peers
Updated Aug 19, 2026
Profit Margin
1.41%
vs Conglomerates peers
Updated Aug 19, 2026
Operating Margin
1.91%
vs Conglomerates peers
Updated Aug 19, 2026
Return on Assets (TTM)
1.18%
vs Conglomerates peers
Updated Aug 19, 2026
Return on Equity (TTM)
5.24%
vs Conglomerates peers
Updated Aug 19, 2026
Revenue (TTM)
6.85TKRW
4.85B · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
35.33KKRWUpdated Aug 19, 2026
Quarterly Revenue Growth
6.50%
vs Conglomerates peers
Updated Aug 19, 2026
Gross Profit (TTM)
884.75BKRW
626.44M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
285.10BKRW
201.86M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
107.00BKRW
75.76M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
6.52%
vs Conglomerates peers
Updated Aug 19, 2026
Operating Cash Flow (TTM)
365.09BKRW
258.50M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
548.10BKRW
388.07M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing Annual Dividend Rate
200.00KRWUpdated Aug 19, 2026
Trailing Annual Dividend Yield
2.69%
vs all stocks
Updated Aug 19, 2026
5-Year Average Dividend Yield
2.38%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
45.37%
vs Conglomerates peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 77.82%.Updated Aug 19, 2026
Minority Interest (Equity)
1.87BKRWFY2025 · Dec 31, 2025
Revenue
6.75TKRWFY2025 · Dec 31, 2025
Cost of Goods Sold
5.88TKRWFY2025 · Dec 31, 2025
Gross Profit
868.24BKRWFY2025 · Dec 31, 2025
Operating Income
86.29BKRW
61.10M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
61.12BKRWFY2025 · Dec 31, 2025
Income Tax Expense
1.76BKRWFY2025 · Dec 31, 2025
Net Income
49.98BKRWFY2025 · Dec 31, 2025
EBIT
125.24BKRWFY2025 · Dec 31, 2025
EBITDA (Income Statement)
265.80BKRWFY2025 · Dec 31, 2025
Selling, General & Administrative
340.61BKRWFY2025 · Dec 31, 2025
Other Operating Expenses
30.86BKRWFY2025 · Dec 31, 2025
Non-operating Interest Income
12.95BKRWFY2025 · Dec 31, 2025
Non-operating Interest Expense
64.12BKRWFY2025 · Dec 31, 2025
Net Income from Continuing Operations
49.98BKRWFY2025 · Dec 31, 2025
Minority Interests (P&L)
-160.00MKRWFY2025 · Dec 31, 2025
Operating Cash Flow
50.02BKRWFY2025 · Dec 31, 2025
Free Cash Flow
-18.97BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
448.42BKRWFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
49.98BKRWFY2025 · Dec 31, 2025
Stock-based Compensation
-341.00MKRWFY2025 · Dec 31, 2025
Other Non-cash Items
52.53BKRWFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-97.82BKRWFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
45.66BKRWFY2025 · Dec 31, 2025
Capital Expenditures
-68.99BKRWFY2025 · Dec 31, 2025
Net Intangibles (CF)
-1.27BKRWFY2025 · Dec 31, 2025
Net Acquisitions
32.96BKRWFY2025 · Dec 31, 2025
Purchase of Investments
-18.14BKRWFY2025 · Dec 31, 2025
Sale of Investments
127.44BKRWFY2025 · Dec 31, 2025
Other Investing Activity
3.10BKRWFY2025 · Dec 31, 2025
Net Investing Cash Flow
76.37BKRWFY2025 · Dec 31, 2025
Long-term Debt Issuance
648.04BKRWFY2025 · Dec 31, 2025
Long-term Debt Payments
-850.60BKRWFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
-850.60BKRWFY2025 · Dec 31, 2025
Common Stock Repurchase
-5.00MKRWFY2025 · Dec 31, 2025
Common Dividends Paid
-48.51BKRWFY2025 · Dec 31, 2025
Other Financing Charges
-1.64BKRWFY2025 · Dec 31, 2025
Net Financing Cash Flow
-1.10TKRWFY2025 · Dec 31, 2025
Shares Outstanding
193.95MSharesUpdated Aug 19, 2026
Float Shares
94.81MSharesUpdated Aug 19, 2026
% Held by Insiders
49.01%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
14.06%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
1.03TKRW
732.75M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
5.34KKRWUpdated Aug 19, 2026
Total Debt (MRQ)
1.85TKRW
1.31B · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.8649x
vs Conglomerates peers
Updated Aug 19, 2026
Current Ratio (MRQ)
0.9660x
vs Conglomerates peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
11.02KKRWUpdated Aug 19, 2026
Total Assets
5.04TKRW
3.57B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.83TKRWFY2025 · Dec 31, 2025
Total Liabilities
3.02TKRWFY2025 · Dec 31, 2025
Total Non-current Assets
3.21TKRWFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.23TKRWFY2025 · Dec 31, 2025
Total Current Liabilities
1.78TKRWFY2025 · Dec 31, 2025
Cash
442.87BKRWFY2025 · Dec 31, 2025
Cash Equivalents
5.54BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents
448.42BKRWFY2025 · Dec 31, 2025
Other Short-term Investments
109.67BKRWFY2025 · Dec 31, 2025
Accounts Receivable
512.43BKRWFY2025 · Dec 31, 2025
Inventory
356.38BKRWFY2025 · Dec 31, 2025
Accounts Payable
682.86BKRWFY2025 · Dec 31, 2025
Short-term Debt
753.56BKRWFY2025 · Dec 31, 2025
Long-term Debt
1.09TKRWFY2025 · Dec 31, 2025
Common Stock (Book)
620.47BKRWFY2025 · Dec 31, 2025
Retained Earnings
756.48BKRWFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.03TKRW
1.43B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
144.12BKRWFY2025 · Dec 31, 2025
52-Week Low
4.28KKRWUpdated Aug 19, 2026
52-Week High
16.24KKRWUpdated Aug 19, 2026
52-Week Change
64.02%
vs all stocks
Updated Aug 19, 2026
Beta
1.24x
vs all stocks
Updated Aug 19, 2026
50-Day MA
9.22KKRWUpdated Aug 19, 2026
200-Day MA
6.45KKRWUpdated Aug 19, 2026
Avg 10-Day Volume
1.09MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
1.54MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
257.00KRWUpdated Aug 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.96: grey zoneSignificant
Altman Z-Score: 1.96
Low earnings qualitySignificant
Earnings Quality Score: -1.46
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Revenue is $4.85B, above the global median of $520.53MNotable